Adding CDK4/6 Inhibitors to Metastatic Breast Cancer Therapy Adding CDK4/6 Inhibitors to Metastatic Breast Cancer Therapy

How are these agents used in treatment? We asked the experts.Medscape Oncology

Source: Medscape Today Headlines - March 18, 2020 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news